Skip to main content
CivicGate

S 5059
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

To amend the Public Health Service Act to streamline the review of biosimilar biological products.

Introduced Jul 21, 2026

Latest action (Jul 21, 2026) Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Referred to
Health, Education, Labor, and Pensions Committee
Issues
Healthcare

Summary

This bill would amend the Public Health Service Act to streamline the review process for biosimilar biological products. It modifies Section 351(k)(5) by removing one regulatory subparagraph and renumbering a subsequent subparagraph. The amendments are technical adjustments to the existing biosimilar review framework.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
3 cosponsors

Actions (2)
  1. Jul 21, 2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
  2. Jul 21, 2026 Introduced in Senate

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

  • HR 9661 — Expedited Access to Biosimilars Act · Introduced Jul 14, 2026 · Cong. 119 73%
  • S 1414 — Expedited Access to Biosimilars Act · Introduced Jul 22, 2026 · Cong. 119 68%
  • S 1954 — Biosimilar Red Tape Elimination Act · Introduced Jun 17, 2026 · Cong. 119 67%
  • HR 5526 — Biosimilar Red Tape Elimination Act · Introduced Sep 19, 2025 · Cong. 119 66%
  • S 3510 — Biosimilar Inspection Modernization Act of 2025 · Introduced Dec 16, 2025 · Cong. 119 65%
  • S 3469 — BIOSECURE Act of 2025 · Introduced Dec 11, 2025 · Cong. 119 64%

Text versions (1)
  • Introduced in Senate · Jul 21, 2026

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE SENATE OF THE UNITED STATES

July 21, 2026

Mrs. Moody (for herself, Ms. Alsobrooks, Mr. Scott of Florida, and Ms. Blunt Rochester) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend the Public Health Service Act to streamline the review of biosimilar biological products.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. STREAMLINING BIOSIMILAR REVIEWS.

Section 351(k)(5) of the Public Health Service Act (42 U.S.C. 262(k)(5)) is amended—

(1) by striking subparagraph (B); and

(2) by redesignating subparagraph (C) as subparagraph (B). <all>

Comments

Comments

Loading comments…